[Portal and superior mesenteric venous thrombosis treated with urokinase infusion via superior mesenteric artery]

Korean J Gastroenterol. 2006 Jul;48(1):46-50.
[Article in Korean]

Abstract

Portal and mesenteric venous thrombosis is an uncommon disease, but clinically important, because it accounts for 5% to 15% of acute mesenteric ischemia. The diagnosis is often delayed because the conditions are nonspecific abdominal symptoms. In addition, when this occurs in young individual without any known predisposing factor, the diagnosis may become even more difficult. The treatment of mesenteric venous thrombosis involves anticoagulation therapy alone or in combination with surgery. The addition of thrombolytic therapy to the treatment of portal and mesenteric venous thrombosis may enhance the clearance of thrombus and hasten the clinical improvements. We present a case of mesenteric venous thrombosis treated with catheter-directed infusion of urokinase via the superior mesenteric artery and systemic anticoagulation.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Humans
  • Infusions, Intra-Arterial
  • Male
  • Mesenteric Artery, Superior
  • Mesenteric Vascular Occlusion / drug therapy*
  • Mesenteric Veins
  • Portal Vein*
  • Thrombolytic Therapy*
  • Urokinase-Type Plasminogen Activator / administration & dosage*
  • Venous Thrombosis / drug therapy*

Substances

  • Urokinase-Type Plasminogen Activator